当前位置:首页 > 文献互助 > 互助详情

Post-marketing safety surveillance of the novel muscarinic antipsychotic Xanomeline-Trospium for schizophrenia: A comparative disproportionality analysis against …复制

用户dO6Bp_vxHIqQ 22分钟前 15 10 求助中 帖子自动结束时间: 2026-07-29 11:26:03

1. 文件大小不能超过300M, 允许上传文档或压缩包等

2. 请确保上传文献的真实性、完整性,不得对原文做任何修改

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI:复制

文献链接:复制

其他信息:

Y Zeng, X Wang, H Wu, X Tan, R Wang, Y Liu…
Psychiatry Research, 2026
Elsevier
Objective: To characterize the real-world post-marketing safety reporting profile and adverse event (AE) signals of Xanomeline-Trospium, a novel dual M1/M4 muscarinic antipsychotic for schizophrenia. Methods: FAERS data from 2024Q4 to 2025Q4 were retrospectively analyzed. Reports listing Xanomeline-Trospium as the primary suspected drug were extracted. Signals were detected using four algorithms: ROR, PRR, BCPNN, and MGPS. Additional analyses included Weibull time-to-onset modeling, exploratory comparison with …

互助时间线

2026-07-24 11:26:03 [发起求助]

最新发布的求助